Walgreens Boots Alliance (NASDAQ:WBA) Announces Earnings Results

Walgreens Boots Alliance (NASDAQ:WBA) issued its quarterly earnings results on Thursday. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.04), Briefing.com reports. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. During the same period in the previous year, the company posted $1.00 earnings per share. Walgreens Boots Alliance’s revenue was up 2.8% compared to the same quarter last year. Walgreens Boots Alliance updated its FY 2024 guidance to 2.800-2.950 EPS and its FY24 guidance to $2.80-$2.95 EPS.

Walgreens Boots Alliance Trading Down 22.2 %

Shares of WBA stock opened at $12.19 on Friday. Walgreens Boots Alliance has a 12 month low of $11.68 and a 12 month high of $31.32. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The business’s 50 day moving average is $16.72 and its two-hundred day moving average is $20.33. The company has a market cap of $10.52 billion, a PE ratio of -1.74, a price-to-earnings-growth ratio of 0.98 and a beta of 0.78.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were issued a dividend of $0.25 per share. The ex-dividend date was Monday, May 20th. This represents a $1.00 annualized dividend and a yield of 8.20%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.29%.

Insider Buying and Selling at Walgreens Boots Alliance

In related news, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction on Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. Corporate insiders own 17.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on WBA shares. Raymond James reissued a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. UBS Group cut their price objective on Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating on the stock in a report on Monday. Truist Financial restated a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Barclays cut their price objective on Walgreens Boots Alliance from $21.00 to $19.00 and set an “underweight” rating on the stock in a report on Monday. Finally, Evercore ISI cut their price objective on Walgreens Boots Alliance from $18.00 to $17.00 and set an “in-line” rating on the stock in a report on Monday, June 3rd. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $23.07.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.